Institut Gustave Roussy / Service d'Immunotherapie

Villejuif 94805

0 studies enrolling now · 2 studies all time

What they study most

Kidney Neoplasms

Studies at this site

• Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer — Completed
• A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer — Completed